CompletedPhase 1/2

Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II

4 participantsStarted 2012-01-01

Plain-language summary

Study of ORL-1F in Patients With Leukocyte Adhesion Deficiency Type II

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of Leukocyte Adhesion Deficiency Type II. * Less than 18 years old. Exclusion Criteria: * Diagnosis of any other disease that is not a manifestation of Leukocyte Adhesion Deficiency Type II.

What they're measuring

Decrease in infection frequency

Timeframe: 12 months after treatment started

Trial details

NCT IDNCT03354533

SponsorOrpha Labs

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2018-11-01

View on ClinicalTrials.gov More Leukocyte Adhesion Deficiency, Type II trials